相关实验视频
Updated: Jul 5, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
脑卒中心脏综合征中的血栓溶解:神经心脏健康的有用工具?
Ilario Scali1, Marcello Naccarato2, Gabriele Prandin2
1Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Clinical University Hospital of Trieste (ASUGI), University of Trieste, Strada di Fiume 447, 34149, Trieste, Italy. scalilario@gmail.com.
Journal of neurology
|January 11, 2024
概括
血栓切除术前的血栓溶解可能会减少急性缺血性中风后的心脏损伤. 这种"桥梁"治疗改善了与单独直接血栓切除相比,患者的治疗结果.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 干预医学是干预的医学.
背景情况:
- 脑中风心脏综合征涉及主要血管封闭导致的脑损伤后的心脏问题.
- 心脏生物标志物,如热波宁,可以表明与中风有关的心脏损伤.
- 这项研究探讨了血栓溶解作为减轻这种综合征的潜在治疗方法.
研究的目的:
- 研究血栓溶解在急性缺血性中风后减少中风心脏综合征的辅助作用.
- 为了比较不同治疗策略之间的心脏生物标志物水平和功能结果.
主要方法:
- 对120名急性缺血性中风患者的回顾性分析,前部循环封闭.
- 患者被分为两组:"桥梁" (血栓溶解+血栓切除术) 和"直接" (仅进行血栓切除术).
- 排除标准包括先前的缺血性心脏病.
主要成果:
- "桥梁"组 (92名患者) 在72小时内显著降低了峰值热素 (16vs45 ng/L) 和BNP (455vs784 pg/mL) 水平.
- 在"桥"组 (36%与10%相比) 中,释放时的功能独立性 (mRS 0-2) 显著更高.
- 两组之间没有观察到年龄,基线NIHSS或心血管风险因素的显著差异.
结论:
- "桥梁"方法 (血栓溶解随后进行血栓切除术) 可能减少急性缺血性中风后的心脏功能障碍 (中风心脏综合征).
- 这种联合治疗似乎可以改善神经系统的结果和功能独立性.
- 血栓溶解可能在中风治疗期间对心脏产生补充性保护作用.
相关概念视频
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Exercise and Cardiovascular Response
815
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
815
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K

